ICOS Corporation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ICOS Corporation

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (577)	11/23/1998 2:27:00 PM
From: DJ	Read Replies (1) of 1139

I read the Business Week article -- it is the best all-around piece I've seen on George Rathmann's career and what makes him keep going to work at the age of 70 (he loves business AND science). The only themes that the article didn't fully develop, but which may be discussed in future journalistic forays on ICOS, are: (1) the rather broad range (a dozen or so, I think) of drugs under development at ICOS, and (2) the serious intellectual interest that Bill Gates has in the whole biotech revolution, perhaps not only because of the increasing use of computers in "bioinformatics" but also his passion for wanting to help invent the future. On the first point, Rathmann was known at Amgen for employing a "targeted diversification" strategy -- which he also seems to be following at ICOS: Raise money for multiple technology developments, and take advantage of serendipitous developments that follow.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next